Covered recipient · General Payments record
TOMAS G NEILAN
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$176,094.12
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,499.75 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $6,459.75 | 6 |
| Amgen Inc. | $4,582.50 | 1 |
| Genentech, Inc. | $2,857.50 | 1 |
| AstraZeneca UK Limited | $1,600.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $4,582.50 | 03/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117639367 | CMS |
| AstraZeneca UK Limited | $1,600.00 | 11/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110548170 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,900.00 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101229309 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,087.50 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101229319 | CMS |
| E.R. Squibb & Sons, L.L.C. | $362.50 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101229321 | CMS |
| E.R. Squibb & Sons, L.L.C. | $783.00 | 04/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101229327 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,087.50 | 05/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101229333 | CMS |
| E.R. Squibb & Sons, L.L.C. | $239.25 | 06/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101229335 | CMS |
| Genentech, Inc. | $2,857.50 | 06/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133126731 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.